MC10 today released its BioStamp Research Connect system, a flexible, wearable sensor that gathers physiological data, and announced a partnership with L’Oreal to create the My UV Patch stretchable skin sensor designed to monitor UV exposure.
The BioStamp RC is the 1st product that fully integrates the company’s BioStamp tech, which connects to the company’s cloud-based software, and allows researchers to share data with each other across multiple research sites. Patches can be used simultaneously on multiple body locations, the company said.
“We are very impressed with the results of the BioStamp system tests that we have performed so far. The sensor is unobtrusive, very comfortable to wear, and it reliably collects data for extensive periods. Charging the sensor’s battery and checking the quality of the data being collected is simple. The system appears to be an ideal platform for many of our clinical research projects,” Spaulding Rehab Hospital motion analysis lab director Dr. Paolo Bonato said in a press release.
The product allows researches to gather raw kinematic and surface biopotential data through a 3-axis accelerometer and 3-axis gyroscope and integrated electrodes to gather surface electromyography and electro-cardiac activity.
“MC10’s mission is to create digital healthcare products that can better our understanding of, and ultimately improve, human health. The BioStampRC system is a great example of this mission,” CEO Scott Pomerantz said in prepared remarks.
The company expects to release the product in early 2016.
MC10 also released its L’Oreal partnered MyUV Patch, a 1 inch transparent adhesive that contains photosensitive dyes that factor in skin tone and change colors when exposed to UV rays to indicate levels of sun exposure.
“Connected technologies have the potential to completely disrupt how we monitor the skin’s exposure to various external factors, including UV. Previous technologies could only tell users the amount of potential sun exposure they were receiving per hour while wearing a rigid, non-stretchable device. The key was to design a sensor that was thin, comfortable and virtually weightless so people would actually want to wear it. We’re excited to be the first beauty company entering the stretchable electronics field and to explore the many potential applications for this technology within our industry and beyond,” L’Oreal technology incubator global veep Guive Balooch said in a prepared statement.
Device users can take pictures of the patch and upload them to a custom mobile app which analyzes the dye squares to determine the level of UV exposure. The app will be available on Apple (NSDQ:AAPL) iOS and Google (NSDQ:GOOG) Android devices, with the Android app incorporating near field communications technology.
“With My UV Patch, L’Oreal is taking the lead in developing the next generation of smart skincare technology powered by MC10’s unique, stretchable electronics platform, that truly addresses a consumer need. This partnership with L’Oreal marks an exciting new milestone for MC10 and underscores the intersection of tech and beauty and the boundless potential of connected devices within the beauty market,” CEO Pomerantz said in a press release.
“Together with La Roche-Posay dermatologists like myself, we share a mission to help increase sun safe behavior. La Roche-Posay recently commissioned a global study in 23 countries, which surveyed 19,000 women and men and found a huge gap in consumer behavior: even though 92% were aware that unprotected sun exposure can cause health problems, only 26% of Americans protect themselves all year round, whatever the season. With the new My UV Patch, for the 1st time, we are leveraging technology to help incite a true behavioral change through real-time knowledge,” Dr. Alysa Herman said in prepared remarks.
Both products were premiered at the CES 2016 in Las Vegas.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.